A Pipeline for Integrated Theory and Data-Driven Modeling of Genomic and
  Clinical Data by Raghu, Vineet K et al.
A PIPELINE FOR INTEGRATED THEORY AND DATA-DRIVEN
MODELING OF GENOMIC AND CLINICAL DATA
A PREPRINT
Vineet K. Raghu
Department of Computer Science
University of Pittsburgh
vineet@cs.pitt.edu
Xiaoyu Ge
Department of Computer Science
University of Pittsburgh
xig34@pitt.edu
Arun Balajee
Department of Computer Science
University of Pittsburgh
abl55@pitt.edu
Daniel J Shirer
Department of Computer Science
University of Pittsburgh
djs134@pitt.edu
Isha Das
Department of Computational and Systems Biology
University of Pittsburgh
Panayiotis V. Benos
Department of Computational and Systems Biology
University of Pittsburgh
benos@pitt.edu
Panos K. Chrysanthis
Department of Computer Science
University of Pittsburgh
panos@cs.pitt.edu
May 7, 2020
Abstract
High throughput genome sequencing technologies such as RNA-Seq and Microarray have the potential to
transform clinical decision making and biomedical research by enabling high-throughput measurements of
the genome at a granular level. However, to truly understand causes of disease and the effects of medical
interventions, this data must be integrated with phenotypic, environmental, and behavioral data from individuals.
Further, effective knowledge discovery methods that can infer relationships between these data types are required.
In this work, we propose a pipeline for knowledge discovery from integrated genomic and clinical data. The
pipeline begins with a novel variable selection method, and uses a probabilistic graphical model to understand
the relationships between features in the data. We demonstrate how this pipeline can improve breast cancer
outcome prediction models, and can provide a biologically interpretable view of sequencing data.
Keywords Genomics, Graphical Models, Feature Selection, Phenotype Prediction, Knowledge Discovery
1 Introduction
Since the advent of high-throughput sequencing assays, a number of modeling approaches have been developed to
predict patient outcome from genomic data12,21. To understand the complex relationships between genomics and
outcomes, the genomic data are often merged with clinical and demographic information in an "integrated" dataset. The
reason standard machine learning models have been insufficient to model this data20 are due to its unique complexities.
Specifically, these data have highly correlated sets of variables (genes), and often consist of several orders of magnitude
more variables than samples (high-dimensional). Lastly for biomedical research purposes, predictive power of models
are important, but interpretability of models are equally crucial. Often, biomedical researchers aim to learn from their
models to identify promising new hypotheses or to prioritize future experiments, instead of solely aiming to predict
outcomes accurately.
Probabilistic Graphical Models (PGM’s) are an effective tool to build interpretable models27. These models represent a
dataset as a graph where nodes correspond to features and edges correspond to dependence relationships. Learning the
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Figure 1: Pipeline proposed in this work to learn graphical model structure from mixed clinical and omics datasets.
structure of these models from data is a well-studied problem for continuous data and categorical data but not mixtures
of both. Recently, several approaches have been proposed to model mixed data28,34,36. However, to utilize these
approaches requires addressing some of the aforementioned difficulties inherent to the integrated datasets. Graphical
model learning would be computationally intractable on genome scale data. Further, interpretation of a large graphical
model is difficult unless single variables of interest are queried. Lastly, highly correlated data can result in the formation
of disconnected cliques, impeding model accuracy29.
One way to address these issues is by selecting a subset of variables to model. The machine learning community
refers to this problem as feature selection. There, the aim is to find the subset of features that best predicts a target
variable of interest. Though some of these approaches are applied to integrated biomedical data, they still fail to address
the aforementioned challenges. High correlation among features results in unstable prediction models, and harms
interpretability of learned models23.
Using prior knowledge has been proposed as a way to address these difficulties3,12,41. These sources allow a researcher
to choose the most biologically plausible model among statistically equivalent modelsa23,44. However, many proposed
methods have shown no significant benefit from using prior knowledge12,38. Our hypothesis for this is twofold. First,
external data sources need to be evaluated and weighted accordingly due to data provenance and context-specific
information. For example, a particular biological pathway may not be active in the context from which a genomic
dataset was measured. Thus, this source of information should be downweighted in the final model. Second, multiple
sources of prior information should be integrated to achieve consistent results.
This motivates our pipeline for modeling an integrated genomic and clinical dataset (Figure 1). The first step is to
measure the concordance between the data and each of the prior information sources, and weight the sources accordingly.
This is based upon a prior knowledge evaluation method we recently developed for graphical structure learning30.
Then, the information in the data and the prior knowledge are fused to select parameters for a feature selection method
(Pref-Div). Finally, the clusters selected by Pref-Div are modeled using a graphical model structure learning algorithm
to represent the dependencies between the clusters and outcome variables of interest.
Our specific contributions are as follows:
• A novel method for variable and cluster selection that combines a feature selection approach16 with an
approach to evaluate and integrate prior information30.
• An extensive evaluation of the variable selection approach on synthetic datasets
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• A pipeline that combines variable selection with graphical modeling to represent inter-relationships between
variables from mixed discrete and continuous datasets
• An evaluation of the pipeline against state of the art variable selection approaches in predictiing breast cancer
outcome and subtyping from transcriptomic data.
2 Related Work
In this section, we give background information on feature selection methods for genomic data. Then, we discuss how
prior knowledge has been incorporated. Finally, we discuss graphical model structure learning approaches for mixed
datasets.
2.1 Feature Selection in Genomics
Feature selection aims to identify a subset of features in a dataset that together best predict a target variable18. The main
purpose of feature selection is to improve model training efficiency and to prevent overfitting. In machine learning,
feature selection approaches fall into three broad classes: filter methods, wrapper methods, and embedded methods20.
Filter methods select features using univariate ranking scores such as a Wilcoxon test or a t-test between a covariate and
a target variable. Wrapper methods use a predictive model like the Support Vector Machine to select a set of features that
result in an accurate prediction model25. Two popular wrapper methods are the recursive feature elimination and greedy
forward search, which select the best feature to eliminate (or include, respectively) in a step-wise fashion. Finally,
embedded methods are predictive models which select features automatically as part of the learning procedure. The
most popular example of this is the LASSO regression method42, which uses an L1 norm penalty to shrink coefficients
to zero in a linear regression.
Recently, a study was performed investigating the performance of these techniques to predict breast cancer relapse from
genomic data20. Overall, no method had significantly better accuracy than randomly choosing features and learning a
classification model, and only filter based methods were more stable (insensitive to variations in the data). Since this
was true even within a single dataset, it could only be attributed to the methods themselves. This suggests that tailored
approaches are necessary to improve feature selection from omics data.
2.2 Incorporating Prior Knowledge
One way to improve these approaches is to use domain knowledge about the relationships between genes and between
protein products. Three main sources of prior knowledge have been explored: gene ontology (GO) terms, protein-protein
interaction networks (PPI’s), and biological pathways21.
GO groups genes based on known biological functions (e.g. cell cycle or angiogenesis). Several approaches have
leveraged GO terms as prior information to construct gene clusters9,11,32. The main drawback of these methods is the
nature of GO terms. Not all genes belong to a functional group in the GO, and these methods chose to discard those
genes. In addition, GO terms tend to define broad functional classes which are difficult to interpret.
PPI’s are networks that encode protein interactions known to occur in normal cellular activity. Methods for gene
selection have been built off of these networks, and they were reviewed and evaluated in12. Many of these approaches
aim to either 1) group genes based on the edges in the network and penalize them together3,37,45,50 or 2) use the network
information to determine gene importance25,41. Pathway based approaches are similar in principle, but use biological
pathways which represent a module of the network that carries out a specific function. These are normally taken from a
pathway database such as KEGG or I2D6,26. Biological pathway-based feature selection is a step-wise method that uses
mutual information to the target variable as a scoring criterion, but does not choose multiple genes from the same area
in the graph consisting of the union of all the pathways4. In17, the authors attempt to construct a single feature for each
pathway by aggregating information across multiple genes. A similar method is taken in2 except that the pathways
are constructed using the data. Multiple studies have found no significant benefit in prediction accuracy over baseline
methods; however, these methods do appear to give more biologically interpretable signatures12,38.
2.3 Mixed Graphical Models
For data exploration applications, graphical models enable a user to identify all direct associations for any variable of
interest. Since genomic data is often integrated with clinical, demographic, and epidemiological data, in this work we
focus upon approaches to learn undirected graphical models from mixed datasets: mixed graphical models (MGM). A
MGMl parametrizes the joint distribution of a mixed dataset as a graph G = (V,E), where V is the set of variables and
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E is the set of edges. In this type of model, an edge exists between two variables X and Y if X and Y are conditionally
dependent given the rest of the variables in the data.
Recently several methods have been proposed to learn MGM’s. In43, the authors propose qp-graphs which can be
estimated from high dimensional data.However, this type of model assumes that there are no edges between categorical
variables which is a limiting assumption for clinical data. Several authors have proposed using regression based methods
to estimate the conditional dependencies among pairs of variables to infer the edges in the graph. In these approaches,
each variable in turn is considered as the target variable, a regression is performed using all other variables as predictors,
and edges are added to the model for all significant regressors. In,14, the authors use a random forest regression approach
to rank edges for inclusion into a graphical model among mixed variables. In,48, they assume that the conditional
distributions of each type of variable come from the exponential family and use node-wise regression approaches
to estimate the parameters of the model. Other authors have proposed similar techniques to the aforementioned
methods8,10,15.
Another way to estimate a MGM is the pseudolikelihood approach5. This approach uses the product of conditional
distributions of the variables as a consistent estimator of the true likelihood without computing the partition function.
Then a gradient based optimization method can be used to find maximum pseudolikelihood estimates of the parameters.
Lee and Hastie propose a MGMl that generalizes a popular continuous graphical model (Gaussian Graphical Model)
and a popular discrete model (Markov Random Field)28. They demonstrate that using the pseudolikelihood approach
shows better empirical performance than using separate regressions, and so we focus on this approach.
The authors parameterize the joint distribution of the variables according to Equation 1.
p(x, y; θ) ∝ exp
( p∑
s=1
p∑
t=1
−1
2
βstxsxt +
p∑
s=1
αsxs+
p∑
s=1
q∑
j=1
ρsj(yj)xs +
q∑
j=1
q∑
r=1
φrj(yr, yj)
) (1)
where θ represents the full set of parameters, xs represents the sth of p continuous variables and yj represents the jth of
q discrete variables. βst represents the edge potential between continuous variables s and t, αs represents the continuous
node potential for s, ρsj represents the edge potential between continuous variable s and discrete variable j, and finally
φrj represents the edge potential between discrete variables r and j. This model has the favorable property that its
conditional distributions are given by Gaussian linear regression and Multiclass Logistic Regression for continuous and
discrete variables respectively.
Learning this model over high dimensional datasets directly is computationally infeasible due to the computation of the
partition function, so to avoid this, a proximal gradient method is used to learn a penalized negative log pseudolikelihood
form of the model (Equation 2, product of conditional distributions). To prevent overfitting, nonzero parameters are
penalized using the method described in36 (Equation 3). Here, λCC is a penalty parameter only for edges between
continuous variables (CC = Continuous-Continuous), λCD and λDD are for mixed edges and edges only using discrete
variables, respectively. ||.||F refers to the Frobenius norm of a matrix. To optimize this objective function the proximal
gradient optimization method is used as specified in36.
l˜(Θ|x, y) = −
p∑
s=1
log p(xs|x/s, y; Θ)−
q∑
r=1
log p(yr|x, y/r; Θ) (2)
minimize
Θ
lλ(Θ) = l˜(Θ) + λCC
p∑
s=1
s−1∑
t=1
|βst|+ λCD
p∑
s=1
q∑
j=1
||ρsj ||2 + λDD
q∑
j=1
j−1∑
r=1
||φrj ||F (3)
3 Methods
In this section, we describe the computational methods used to realize our pipeline. First, we discuss our variable
selection method, and then we discuss how we incorporate prior knowledge to select parameters for this method
automatically. Next, we describe the synthetic and real data used to evaluate our approach, and the metrics we apply in
our evaluation. Lastly, we describe the prior knowledge sources used.
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3.1 Variable Selection: Preferential Diversity
The first step in our procedure is to choose variables to model. To this end, we propose to address the following feature
selection problem (Definition 1). We first proposed this problem to identify query results relevant to the user but also
diverse to give a broad snapshot of the underlying data16. The problem was referred to as the Top-K relevant and diverse
set problem, and is as follows.
Definition 1. Top-K Relevant and Diverse Set. Given 0 ≤ r ≤ 1 a radius of similarity, a set of variables V , an output
size k, a similarity function Sim (Vi, Vj), and a relevance function Rel (Vi).
maximize
∑
Xi∈S
Rel (Xi)
subject to S ⊂ V
| S |= k
∀ i, j Vi ∈ S and Vj ∈ S → Sim (Vi, Vj) < r
(4)
Intuitively, we aim to find a set of variables that are relevant to the user with the constraint that no pair of chosen
variables are similar to one another. This is an appropriate choice prior to graphical modeling because graphical models
can lose accuracy if redundant variables are included in the model29. The method we propose to solve this problem
is similar in principle to two filter methods: Correlation-based feature selection19 and maximum relevance minimum
redundancy (mRMR) feature selection13. Both of these are greedy approaches which select the feature that optimizes
an objective function that balances relevance and diversity. The main difference in our approach is that we require zero
redundancy, and that we quantify redundancy using prior knowledge. Lastly, to ensure stability of the downstream
model, we report the selected features as clusters with redundant variables included in each cluster (instead of discarding
them). This allows the user to understand the redundancy in the data.
Another popular approach that follows this principle is the Weighted Gene Correlation Network Analysis (WGCNA)49.
Briefly, this method aims to learn a weighted undirected correlation network by converting correlation to edge weight.
With this network, they infer the dissimilarity between nodes in the network, and use network characteristics (e.g. hub
nodes) to select important genes. This method differs in that it uses network characteristics instead of summary statistics
to infer importance, and the network that they infer is a correlation network whereas graphical models aim to identify
conditional dependence relationships.
Here, we solve this problem using the Preferential Diversity (Pref-Div) algorithm. Pref-Div is an iterative procedure
that first selects the top-K most relevant variables and adds them to the result set R. Then, it determines whether any
pair of variables in R are redundant (as defined by the radius of similarity, r and the similarity function Sim (Vi, Vj)),
and removes the lower relevance variable from the result set. Then, the most relevant K− | R | that have not been
explored are added to the result set. This procedure repeats until a set of K relevant and diverse features are selected.
For the full procedure, we refer the reader to16. In this work, we make one substantial modification from the original
Pref-Div algorithm. Here, we compute all variables considered redundant to the selected set of variables and return
each variable as a cluster.
We instantiate the Pref-Div algorithm with the following parameter choices. The output size k is user-determined since
the appropriate choice for this is based on computational resources available for graphical modeling. Similarity scores
between pairs of features are given by pearson correlation, and relevance of each feature is given by pearson correlation
to a pre-defined target variable. We note that having a target variable of interest is not necessary, and unsupervised
statistics such as variance or domain knowledge can be used to determine relevance scores. In the next section, we
discuss how we select the radius of similarity, λ, using prior knowledge.
3.2 Prior Information Pref-Div: piPref-Div
To choose λ∗, we utilize a method we originally developed to select hyperparameters to learn graphical model structure30.
Here, we briefly summarize the approach for variable selection: called piPref-Div (Prior Information Pref-Div). The
main idea is to compute a correlation graph across many different correlation thresholds, λ∗. A correlation graph
contains an edge between V1 and V2 if the correlation between V1 and V2 is greater than the correlation threshold. This
method proceeds in four major steps.
First, an appropriate parameter range is determined. This is done by identifying a range where the fewest edges are
selected (correlation graph is sparse) yet changing λ slightly results in a large change in the number of edges in the
graph. Figure 2a shows a plot of the number of edges in the correlation graph vs. λ. Initially, a knee point is identified
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(a) Illustration of procedure to limit tested parameter range.
(b) Subsampling procedure to determine empirical proba-
bilities for every edge in the correlation graph. B (λ, S)
returns a correlation graph computed upon dataset S with
threshold λ.
that best splits the curve into two straight lines (Panel a). Then, this procedure is repeated on each partition of the curve
to compute two additional knee-points (Panels b and c). The final parameter range is the space between these two
knee-points (Panel d).
Then, a subsampling approach is used to compute empirical probabilities of appearance for each edge by computing
correlation graphs across the chosen range of thresholds and random subsamples without replacement. The empirical
probability of each edge is its frequency of appearance.
Next, the information contained in the prior knowledge sources are evaluated against these empirical probabilities
across all edges (Equation 5). Each prior information source (tr) gives knowledge in the form of a probability of
appearance for some fixed set of edges (wptr ). τtr quantifies the "unreliability" of source tr. φ
tr
k is the expected number
of times edge k should appear during the subsampling procedure according to source tr, and µk is the actual number of
appearances for edge k.
τtr =
∑|wptr |
k=1 | φtrk − µk |
| wptr | (5)
Finally, posterior distributions are computed for each edge (Figure 2b). For each edge k, a normal distribution is used
to approximate the probability of appearance for each prior source (red, green, and blue curves in Panel a). Using
a normalized reciprocal of the scores computed in the previous step, these normal distributions are combined into a
weighted mixture (black curve, Panel a). This mixture distribution is approximated by the normal distribution which
has minimal KL-divergence to the mixture (Panel b). Finally, this normal distribution is combined with a normal
distribution from the empirical probabilities to get a posterior distribution (Panel c, blue curve).
Since some edges may not have prior information from any of the sources, λ∗ is split into two parameters: one for edges
where prior information is available λ∗wp and one for edges where it is not, λ
∗
np. λ
∗
wp is chosen based upon stability of
the correlation graph across subsamples along with concordance to the posterior distribution for each feature. λ∗np is
chosen the same way, except that the posterior distribution is the one computed from the data alone (pink curve, Panel
c).
3.3 Simulated Datasets
Simulated datasets were used to ensure algorithmic correctness and to understand the impact of prior information
sources. Data was generated from a linear Gaussian graphical model. Edge coefficients were drawn uniformly at
random from the set [−1.5,−0.5] ∪ [0.5, 1.5]. Error terms for each variable were zero mean with variance randomly
drawn from the set [0.01, 2]. Graphical structure was simulated using a "clustered simulation" (Figure 3). Here, each
variable belonged to one of C clusters. In these clusters, each pair of variables in the cluster were connected by an
edge. c < C clusters had one randomly chosen variable connected to the target variable (relevant clusters), while the
remaining C − c clusters were disconnected from the rest of the network. Each cluster consisted of an equal number of
variables. To represent a master regulator and force correlated structure, each cluster had a single latent (unmeasured)
variable that influenced the value of all variables in the cluster.
Prior knowledge was simulated for two types of prior information sources: reliable priors and unreliable priors. All
prior sources give information based on a beta distribution; however, the parameters of this distribution differ based on
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Figure 3: Cluster Simulation to generate simulated datasets. Purple nodes are master regulators of a cluster, blue nodes
are causal parents of the target variable, and the beige node is the target variable.
the type of prior and whether the variables in question belong to the same cluster. An unreliable prior gives information
drawn from Beta (4, 4) for both true and false edges (cluster memberships), whereas a reliable prior draws from
Beta (10, 2) for true edges, and Beta (2, 10) for false edges. The amount of prior information varies based on the
experiment. To determine whether prior information is available for each edge, each edge gets a value b v U (0, 1), and
each prior information source has a value c ∈ [0, 1]. The prior gives information about the relationship if b < c. In this
way, the simulated data reflects the fact that some relationships are more well-studied than others.
We evaluate piPref-Div on its ability to incorporate unreliable prior information in order to select relevant clusters more
accurately. The metric we use for evaluation of selected clusters on simulated data is called cluster accuracy. The goal
of this metric is to compare the relevant clusters output by piPref-Div to the truly relevant clusters in the data generating
graph, where a relevant cluster is a cluster with at least one variable that is a parent of the target variable. First, an
optimal matching is computed between the predicted and actual clusters using the Hungarian Algorithm. The cost of
assigning a predicted cluster to an actual cluster is given by 1 - the Jaccard similarity between the clusters. If multiple
predicted clusters are best assigned to the same actual cluster, these clusters are combined. Finally, the average Jaccard
similarity between the combined predicted clusters and their matched actual clusters are computed as the score.
3.4 Gene Expression Datasets
To evaluate the performance of piPref-Div, we apply it to six publicly available breast cancer Affymetrix HGU133A
microarray datasets. These datasets have been used in several previous analyses and represent a baseline to evaluate
prediction methods12,20,38. Each dataset consists of microarray expression data for between 159 and 286 patients, and
the target variable of interest in this data was whether or not the patient had relapse free survival (RFS)l for 5 years
for four of the datasets. For two sets, this information was unavailable and metastasis free survival (MFS) was used
(Schmidt et al. and Ivshina et al.). Our evaluation consists of a five-fold cross validation within each dataset to determine
how well the selected features give predictive models that are generalizable (accurate) and stable. To measure accuracy,
we use area under the ROC curve (AUC) comparing the probability predictions from each method and true binary
outcome of RFS and MFS for five years. To measure stability, we use the average tanimoto set similarity (intersection
divided by union) for the set of features selected in each fold.
To evaluate the potential of our full pipeline to discover knowledge from data , a graphical model was learned from the
TCGA-BRCA RNA-Seq expression dataset. This data included gene expression measurements from 784 breast tumor
samples and 13,994 genes. Breast cancer sub-type information for each tumor sample was obtained from24. Breast
cancer diagnosis and prognosis are commonly divided into four main subtypes: Luminal A, Luminal B, HER2+, and
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Triple-Negative breast cancer. The main driving distinction for these subtypes is the presence or absence of hormone
receptors on the tumor cell surface, which can lead to varying prognoses. In these experiments, we aim to identify
clusters distinguishing the four sub-types from expression data. To determine stability of each of these clusters, a
10-fold cross validation was done, and the stability of each cluster was the number of times a similar cluster (similarity
> 0.85) was selected in each fold.
3.5 External Prior Knowledge Sources
Prior knowledge consisted of five distinct sources of information. Physical gene distance explored the base pair distance
between two genes on the chromosome. If two genes were on separate chromosomes, then this value was set to zero.
Otherwise given gene Gi from base pairs B1i to B
2
i and gene Gj from base pairs B
1
j to B
2
j , and full chromosome length
C, the physical distance prior is given by Equation 6. This represents the proportion of chromosome distance covered
by the space between these two genes.
Phys (Gi, Gj) = 1−
max
(
B2i , B
2
j
)−min (B1i , B1j )
C
(6)
Gene family information was curated from the Human Genome Organization (HUGO). Gene families are groups of
genes related by sequence and/or function. A single gene can belong to multiple gene families. Thus, we represent
each gene as a vector of families with one-hot encoding. To compute the similarity between these vectors, we use the
Jaccard similarity metric which is the number of families in common divided by the total number of unique families
either gene belongs to. A similar approach is used for gene-disease mapping from the DisGeNet33. This database gives
scores quantifying the level of knowledge that a change in a gene is related to a disease. We use the guilt by association
principle to compute whether two genes are related. We represent a gene by a vector of scores to the diseases in the
database, and we compute the cosine similarity between two gene vectors. Since all scores are positive, this metric is
positive, and is used directly as a probability.
Finally, we use gene-gene similarity data from two sources: Harmonizome35 and STRING40. Harmonizome similarity
data was curated from the Molecular Signatures Database39 and consisted of correlation between gene expression
across several microarray experiments. STRINGdb curates gene-gene relationship scores based on several factors such
as: co-expression, literature co-occurrence, experimental evidence, other databases, etc. STRINGdb scores were scaled
from their (0, 1000) range to (0, 1).
4 Results
Next, we demonstrate the performance of piPref-Div on simulated and real datasets. First, we evaluate its ability to
determine reliable prior information sources and incorporate those sources to select better clusters. Next, we evaluate
the method in terms of its ability to accurately predict outcome for breast cancer patients, and lastly, we use the full
pipeline to learn a graphical model of breast cancer subtype discrimination.
4.1 Evaluation and Impact of Prior Knowledge
First, we tested the ability of piPref-Div to accurately evaluate prior knowledge sources on simulated datasets of 500
variables with 50 clusters (25 relevant), 200 and 50 samples, and 5 prior knowledge sources (3 reliable) with a random
amount of prior information. The results are presented in Figure 4. Here the "Actual Reliability" on the y-axis refers to
the sum of the probabilities given to true edges minus the sum of the probabilities given to false edges for each prior.
The predicted weight for each prior knowledge source given by piPref-Div shows a clear association to the reliability
score. A benefit of this approach is that this weight does not appear to be dependent on the amount of prior information.
Even with little prior information (blue circles), piPref-Div assigns an accurate weight to the knowledge sources.
The next experiment investigated the impact of the amount and quality of prior knowledge on the ability for piPref-Div to
identify relevant clusters of variables in the data. In these experiments, we test the method using the same experimental
parameters as the prior knowledge evaluation section, and using a larger dataset with 3000 variables, 300 clusters (75
relevant). For each experimental setting, 15 graphs were generated and the results are presented cumulatively over these
graphs.
The results for the small datasets are given by Figure 5. Sample size is clearly the most significant factor in determining
accuracy of the selected clusters. Prior information gives a modest improvement in accuracy, but this benefit only occurs
with at least 50% of prior information and at least 3 reliable sources out of 5. However, when all sources are unreliable,
there is no decrease in accuracy unless there is a large amount of information present. Lastly, we note that the benefit of
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Figure 4: Predicted Weight vs. True Reliability for each prior knowledge source in simulated experiments for piPref-Div
for (left) 50 samples and (right) 200 samples.
Figure 5: Accuracy of predicted clusters for varying amount and reliability of prior knowledge. Sample size was set to
50 (left) and 200 (right).
prior information is drastically reduced in cases with sufficient sample size (200 sample case). This is intuitive, as with
more data, correlation becomes a very stable measure, and prior information can be ignored.
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Figure 6: Accuracy of predicted clusters for varying amount and reliability of prior knowledge on large datasets. Sample
size was set to 50 (left) and 200 (right).
Lastly, we examined the ability of piPref-Div to detect clusters from a larger graph (Figure 6). Here, the pattern is
largely similar, except the impact of prior knowledge is more significant. In particular, even 25% prior information
gives a substantial increase in accuracy over having no prior information at all. Again, this impact is larger when the
sample size is small, though it is present in both cases. Further, the impact of more samples is more pronounced in
the larger dataset. An increase from 50 to 200 samples results in an increase in accuracy from 0.65 to over 0.8 for all
amounts of prior.
4.2 Breast Cancer Outcome Prediction
To determine the performance of piPref-Div on real datasets, we applied the algorithm to the aforementioned breast
cancer microarray datasets. Three variations of piPref-Div were tested. piPref-Div alone (PD), piPref-Div with
and without prior information (No Prior = NP) with clusters aggregated into summarized features using principal
component analysis (PD-PCA,PDNP-PCA). For the Pref-Div approaches, an inner 3-fold cross-validation loop was
used to determine the number of selected features (1,3,5, and 10 features were tested). Genes with less than 0.5 standard
deviation across samples in the training set were removed from the dataset prior to feature selection. For comparison
purposes, two methods that performed well in a previous study were included in the analysis: Hybrid-Huberized SVM
(HH-SVM) and Recursive-Reweighted Feature Elimination (RRFE)12.
Figure 7 presents the accuracy results. Across the datasets, the consistent best performing methods are PD-NP-PCA
and PD-PCA (sea-green and light blue, respectively). This suggests that cluster selection and representing individual
features as clusters offers a benefit to selecting single genes alone. However, this is dataset dependent, as Pref-Div alone
(PD, yellow box) matches these methods on 2 of the datasets (Sotiriou and Desmedt) and performs better on 1 dataset
(Wang). Overall, these results show no significant difference between using prior information (PD, PD-PCA) and not
using prior information (PD-NPPCA). Using prior information with PCA clustering shows a slight improvement on the
Ivshina dataset, but none of the others. We find that our approach performs about the same in terms of accuracy when
compared to SVM-RRFE, but our method tends to select significantly fewer features.
Figure 9 presents the stability of the learned models. The results confirm previous work that identifying a stable model
for breast cancer outcome prediction is a difficult problem12. In general, only the RRFE algorithm shows somewhat
consistent stability; however, we note that a major contributing factor is that this algorithm uses on average 119 selected
features, whereas HH-SVM averages around 6 and the PD approaches average around 1 feature (or cluster). Among,
the Pref-Div based approaches, PD-PCA with and without prior information show the most consistent stability. On
nearly all datasets they are near to, or on par with RRFE despite choosing significantly fewer features.
10
A pipeline for integrated theory and data-driven modeling of genomic and clinical data A PREPRINT
Figure 7: AUC of predicting RFS using several feature selection methods on six independent breast cancer microarray
datasets.
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Figure 8: Graphical model of breast cancer subtype. Size of each edge represents the number of times a similar cluster
was selected to be related to Subtype in each of the cross-validation folds.
4.3 Stratification of Breast Cancer Subtypes
Finally, we evaluate our full pipeline of variable selection and then graphical modeling based on its ability to mine
interesting clusters related to breast cancer subtype. Based on the previous section, we chose to use PD-PCA for
variable selection due to its consistently high accuracy and relatively high stability. An MGM model was learned on
a dataset consisting of only the selected clusters and the Subtype variable. To summarize clusters into single names,
the Ingenuity Pathway Analysis regulator analysis was used, and the KEGG Pathway database was queried (corrected
p-values < 0.05 were chosen as candidates). Following this step, only specific pathways and regulators were included as
names of the clusters.
The learned graphical model is presented in Figure 8. We found that two clusters were unable to be mapped coherently
to any biological function (single gene representatives were TMEM41A, and TSPAN15); however, these clusters
were relatively unstable. The two most stable clusters were: Fanconi Anemia/ Hereditary Breast Cancer pathway,
and a set of genes regulated by MYCN. Fanconi Anemia and the Hereditary Breast Cancer pathways are known to
share common genes1, and developing breast cancer through a genetic basis tends to be associated with ER+ breast
cancer31. MYC family pathways and the transcription factors themselves are known to be differentially expressed
across subtypes, and the MYCN factor in particular has shown differences between triple-negative and other subtypes22.
FOXA1 along with GATA3 and ESR1 are necessary for maintaing a luminal phenotype of breast cancer7, and AGR2 is
upregulated by FOXA1 but only in an estrogen receptor dependent manner47. This implies that the FOXA1-AGR2
loop will only be upregulated in ER+ breast cancer. Though it is unclear how KRT14 regulated genes distinguish
subtypes of breast cancer, it is known that upregulation of KRT14 reduces the ability of breast tumor to metastasize and
invade the extracellular matrix46. Overall, we find that the pipeline constructs and selects reasonable clusters that are
discriminative of breast cancer subtypes. In addition, the pipeline generates novel candidate clusters for scientists to
experimentally probe.
5 Discussion
In this work, we have presented a pipeline to learn graphical model structure from large omics datasets. The pipeline
builds upon previous work in integrating and evaluating prior information to select hyperparameters, and a variable
selection method to identify relevant yet non-redundant sets of features. We have extended this approach to return
clusters of variables instead of individual features, and to use these features as input to a graphical model structure
learning algorithm to find interesting relationships within the clusters and between clusters and phenotypes.
We evaluated our work on both synthetic data and real breast cancer data. On the synthetic data, we find that our method
is able to accurately evaluate prior information, and utilize this information to improve the selection of relevant clusters.
In addition, the method avoids performing more poorly than having no prior information at all, when most of the prior
information available is unreliable. We find that the largest improvement over having no prior information occurs when
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there are few samples and a large number of features. Overall, we find the improvement when using prior information
to be modest, but this appears to be necessary to avoid poor performance with unreliable priors.
On classification experiments with microarray data, we find that our method performs at par or better with other state of
the art approaches. We find that using PCA to summarize clusters into single variables gives a slight improvement over
selecting single variables alone. We find that when compared to the state of the art approaches, our method selects far
fewer features to achieve similar or better levels of accuracy. When using the full pipeline with graphical modeling to
analyze RNA-Seq data to discriminate breast cancer subtypes, we find that the method identifies reasonable clusters.
Two of the seven clusters did not map to any known biological regulator or pathway, and are candidates for further
investigation.
For future work, we aim to improve upon the accuracy results with reliable prior information. It could be that using the
prior information solely to select hyperparameters is too conservative an approach, and using the posterior distributions
directly can give better results. Since the priors are already being appropriately weighted, the posterior distributions
should be accurate. In addition, we aim to utilize our pipeline with experimental approaches to validate selected clusters
in terms of activity and biological significnce. Finally, the prior information sources used for the biological experiments
were relatively sparse. It is future work to utilize the vast array of gene expression experiments available to construct
priors that cover a wider representation of the genome.
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A Supporting Results
Figure 9: Stability of learned models for predicting RFS using several feature selection methods on six independent
breast cancer microarray datasets.
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